Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 16 with Dr. Revere [double-quote]Rip[double-quote] Kinkel on how to improve patient outreach
ASNI Calgary 2015
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Keystone Symposium: Mechanisms of Pro-Inflammatory Diseases - joint with - Innate Immunity and Determinants of Microbial Pathogenesis
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
Multiple sclerosis: pathogenesis and treatment.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Rituximab does not reset defective early B cell tolerance checkpoints.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Interferon beta-1b
The force awakens: insights into the origin and formation of microglia.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.

Pages